EC
UBX

EcoR1 Capital’s Unity Biotechnology UBX Stock Holding History

EcoR1 Capital’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29,600
Closed -$1.02M – 73
2020
Q3 		$1.02M Buy
+29,600
New +$1.87M 0.07% 46
2019
Q4 		– Sell
-5,140
Closed -$314K – 55
2019
Q3 		$314K Sell
5,140
-99,310
-95% -$7.03M 0.04% 38
2019
Q2 		$9.92M Buy
104,450
+13,789
+15% +$1.17M 1% 21
2019
Q1 		$7.35M Sell
90,661
-6,050
-6% -$686K 0.68% 34
2018
Q4 		$15.7M Hold
96,711
– – 1.57% 20
2018
Q3 		$15.8M Sell
96,711
-71,353
-42% -$11.7M 1.42% 22
2018
Q2 		$25.3M Buy
+168,064
New +$24.6M 2.41% 13

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EcoR1 Capital's UBX Position: Q4 2020 in Review

EcoR1 Capital sold out of Unity Biotechnology (UBX) in Q4 2020, closing a stake of 29,600 shares — an estimated $1.02M sold.

EcoR1 Capital first reported a position in UBX in Q2 2018 and held it in 7 quarters. The position peaked at $25.3M in Q2 2018. 85 funds tracked by Wall St. Rank hold UBX as of Q4 2020.

  • EcoR1 Capital reported no remaining Unity Biotechnology position as of Q4 2020 after selling out during the quarter.
  • EcoR1 Capital sold 29,600 Unity Biotechnology shares in Q4 2020, an estimated $1.02M.
  • EcoR1 Capital first reported a position in Unity Biotechnology in Q2 2018 and held it in 7 quarters.
  • EcoR1 Capital's Unity Biotechnology position peaked at $25.3M in Q2 2018.
  • 85 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2020.

Based on EcoR1 Capital's 13F filing for Q4 2020, filed 16 Feb 2021.